Article

Cardiology Month in Review: August 2022

Our cardiology month in review spotlights the most popular content from the past month. The top content from August 2022 includes new antithrombotic guidance from CHEST, USPSTF recommendation statement on statin use in primary prevention, and coverage of ESC 22, including DELIVER, TIME, and other late-breaking data.

1. CHEST Releases New Guidance for Perioperative Management of Antithrombotic Therapy

On August 11, the American College of Chest Physicians (CHEST) released 44 new evidence-based recommendations in their new guidelines for perioperative management of antithrombotic therapy, which were published with the intention of replacing the 2012 guidelines on the subject. Composed by a 14-member multidisciplinary guideline writing committee, the new guidelines answer 43 population, intervention, comparator, and outcome questions compared with 11 PICO questions in the 2012 guideline.

2. High HDL-C Could Increase Cardiovascular Disease Risk in Men with Hypertension

A study by a team from the University of Naples and Albert Einstein College of Medicine, detail a U-shaped association between HDL-C levels and cardiovascular, with a significantly increased risk of cardiovascular events observed in the low and high HDL-C groups compared to the medium HDL-C group, but investigators noted this risk could not be confirmed among female patients.

3. European Society of Cardiology Congress 2022

Coverage of the European Society of Cardiology Congress 2022. At the meeting, which is held in Barcelona, Span from August 26-29, our editorial team will be providing coverage of the biggest trials and most impactful data from the first in-person ESC Congress since 2019, which includes DELIVER, DANCAVAS, TIME, PANTHER, & more!

4. USPSTF Reaffirms Endorsement for Statin Use in Primary Prevention Settings

The US Preventive Services Task Force (USPSTF) has released a new recommendation statement outlining the group’s stance related to the use of statin therapy for the primary prevention of cardiovascular disease in adult patients.

5. Enhanced Screenings with Smartphone App No Better than Standard Blood Pressure Cuff, Study Shows

A randomized clinical trial comparing use of standard and enhanced self-measurement approaches in more than 2100 individuals, results of HOME BP demonstrate the mean change in systolic blood pressure during the trial was not significantly different among the study arms, with mean reductions of -10.8 (SD, 18) mmHg and -10.6 (SD, 18) mmHg among the enhance and standard self-measured blood pressure groups, respectively.

6. Smartphone Video Analysis Can Identify Narrowing Arteries in Neck

New research from investigators in Taiwan suggests smartphone cameras could be used to identify narrowed arteries in the neck, which investigators suggest could help revolutionize stroke prevention. An analysis using video‐based motion analysis from video captured through a smartphone could help identify and provide a novel noninvasive and noncontact detection method for clinicians.

Check out previous versions of our cardiology month in review!

Related Videos
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Viet Le, DMSc, PA-C | Credit: APAC
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C | Image Credit: APAC
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
Steve Nissen, MD | Credit: Cleveland Clinic
© 2024 MJH Life Sciences

All rights reserved.